On September 16, 2026, we detected 4 new cluster buys including a $1.5M purchase in $CELH by 2 insiders, and 5 notable insider purchases. Wilks Matthew (Director) bought $34.3M of $FTK. Data sourced from SEC Form 4 filings analyzed by Average Insider.
⚠️ For information purposes only. This information is provided for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other type of advice. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. You should consult with a qualified financial advisor, accountant, or other professional before making any investment decisions. The information contained in this newsletter is not intended to be a substitute for professional financial advice.
📊 Insider Trading Insights — September 16, 2026
Tracking insider purchases and cluster buys over the past 7 days. Insider buying can indicate confidence in a company's future, while cluster buys (multiple insiders buying around the same time) are particularly noteworthy signals.
🔥 Cluster Buys
| | |
| Date Range Sep 10, 2026 – Sep 15, 2026 | |
👥 Participant Details
Fieldly John Director | 18,000 shares $493,843 @ $27.44/share 2026-09-10T00:00:00 |
P&L: +0.7% (+$3,497) | DeSantis Damon Director | 20,000 shares $553,000 @ $27.65/share 2026-09-14T00:00:00 |
P&L: -0.1% ($400) |
DeSantis Damon Director | 16,000 shares $447,200 @ $27.95/share 2026-09-15T00:00:00 |
P&L: -1.1% ($5,120) | |
📊 Valuation & Analyst Info
Fair Value: $-54.46 (-297.1% overvalued vs current price)
P/E Ratio: 183.0 (7.1x above Beverages - Non-Alcoholic avg (22.5)) (4.2x above Consumer Defensive avg (34.9))
Analyst Consensus: Buy
Price Target: $41.83 (Low: $26.00 | High: $57.00 | Median: $43.00)
📰 Recent News (Last 7 Days)
| | |
| Date Range Sep 11, 2026 – Sep 14, 2026 | |
👥 Participant Details
Rosebrough Walter M Jr Director | 7,000 shares $378,770 @ $54.11/share 2026-09-11T00:00:00 |
P&L: -1.6% ($5,880) | Keel Paul A Director | 4,701 shares $250,000 @ $53.18/share 2026-09-11T00:00:00 |
P&L: +0.2% (+$423) |
Kurzius Lawrence Erik Director | 10,000 shares $539,150 @ $53.91/share 2026-09-14T00:00:00 |
P&L: -1.2% ($6,450) | Rosebrough Walter M Jr Director | 3,000 shares $162,870 @ $54.29/share 2026-09-14T00:00:00 |
P&L: -1.9% ($3,060) |
📊 Valuation & Analyst Info
Fair Value: $54.90 (+3.1% undervalued vs current price)
P/E Ratio: 37.2 (0.1x below Medical - Instruments & Supplies avg (42.3)) (0.7x above Healthcare avg (22.0))
Analyst Consensus: Buy
Price Target: $65.75 (Low: $59.00 | High: $75.00 | Median: $63.50)
📰 Recent News (Last 7 Days)
| | |
| Date Range Sep 11, 2026 – Sep 11, 2026 | |
👥 Participant Details
Finke Thomas M Director | 200,000 shares $350,000 @ $1.75/share 2026-09-11T00:00:00 |
P&L: -1.7% ($6,000) | ROTH JAY W Director | 200,000 shares $350,000 @ $1.75/share 2026-09-11T00:00:00 |
P&L: -1.7% ($6,000) |
📊 Valuation & Analyst Info
Fair Value: $-29.47 (-1813.3% overvalued vs current price)
P/E Ratio: -7.6
📰 Recent News (Last 7 Days)
| | |
| Date Range Sep 15, 2026 – Sep 15, 2026 | |
👥 Participant Details
Carillo Brooke Chief Financial Officer | 26,065 shares $100,238 @ $3.85/share 2026-09-15T00:00:00 |
P&L: +1.7% (+$1,676) | Abate Christopher J Director | 100,000 shares $383,900 @ $3.84/share 2026-09-15T00:00:00 |
P&L: +1.8% (+$7,100) |
KUBICEK GREG H Director | 50,000 shares $192,560 @ $3.85/share 2026-09-15T00:00:00 |
P&L: +1.5% (+$2,940) | |
📊 Valuation & Analyst Info
Fair Value: $-3.67 (-193.8% overvalued vs current price)
P/E Ratio: -9.4
Analyst Consensus: Buy
Price Target: $6.00 (Low: $5.50 | High: $6.50 | Median: $6.00)
📰 Recent News (Last 7 Days)
💰 Individual Insider Buys
Transaction Date Sep 11, 2026 | | |
Purchase Value $34,320,013 | | |
📊 Valuation & Analyst Info
Fair Value: $-60.40 (-323.9% overvalued vs current price)
P/E Ratio: 19.1 (0.1x below Oil & Gas Equipment & Services avg (21.1)) (0.2x above Energy avg (15.6))
Analyst Consensus: Buy
Price Target: $34.50 (Low: $27.50 | High: $44.00 | Median: $32.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-11-03
Transaction Date Sep 10, 2026 | | |
Purchase Value $10,684,548 | | |
📊 Valuation & Analyst Info
Fair Value: $248.28 (+11.3% undervalued vs current price)
P/E Ratio: 30.9 (0.5x below Waste Management avg (61.1)) (0.8x above Industrials avg (17.3))
Analyst Consensus: Buy
Price Target: $237.25 (Low: $232.00 | High: $249.00 | Median: $234.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-10-29
Transaction Date Sep 10, 2026 | | |
| | |
📊 Valuation & Analyst Info
Fair Value: $16.46 (-53.0% overvalued vs current price)
P/E Ratio: -44.4
Analyst Consensus: Buy
Price Target: $38.50 (Low: $29.00 | High: $45.00 | Median: $38.50)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-11-02
Transaction Date Sep 11, 2026 | | |
| | |
📊 Valuation & Analyst Info
Fair Value: $16.46 (-53.0% overvalued vs current price)
P/E Ratio: -44.4
Analyst Consensus: Buy
Price Target: $38.50 (Low: $29.00 | High: $45.00 | Median: $38.50)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-11-02
Transaction Date Sep 11, 2026 | | |
| | |
📊 Valuation & Analyst Info
Fair Value: $248.28 (+11.3% undervalued vs current price)
P/E Ratio: 30.9 (0.5x below Waste Management avg (61.1)) (0.8x above Industrials avg (17.3))
Analyst Consensus: Buy
Price Target: $237.25 (Low: $232.00 | High: $249.00 | Median: $234.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-10-29
⚠️ Important Disclaimers
Investment Disclaimer: This content is for informational purposes only and should not be considered investment advice.
Data Accuracy: All information is sourced from SEC filings and third-party data providers. Errors or omissions may occur.
Market Risks: Past insider buying activity does not guarantee future performance.
Professional Advice: Consult with qualified financial professionals before making any investment decisions.